Back to company

Eir Diagnostics ApS: Financial statements 2025

CVR: 40339396

Eir Diagnostics ApS (CVR 40339396) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 370,098 and a net result of DKK -16,645,537 compared with DKK -455,658 the year before. Equity amounted to DKK -4,205,596.

Gross Profit
370,098 kr.
Profit/Loss
-16,645,537 kr.
Equity
-4,205,596 kr.
Total Assets
135,530 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-370 t.-16.6 mio.-4.2 mio.0
2024--13 t.-456 t.12.4 mio.1
2023-1.1 mio.-507 t.7.6 mio.3
2022-1.7 mio.-594 t.7.6 mio.4
2021-1.2 mio.-469 t.7.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Eir Diagnostics ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

Eir Diagnostics ApS: The 2024 annual report is outJul 15, 2025

Eir Diagnostics ApS has published its annual report for 2024. Gross profit came to DKK -13,347, and the net result was DKK -455,658.

About Eir Diagnostics ApS

Eir Diagnostics ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2019. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named AptaZense ApS. The management consists of Tine Walldén Jespersen. The company's owners include Danmarks Tekniske Universitet, KEMPHANSEN HOLDING ApS and PLASTISENS ApS. In 2025, the company reported a gross profit of DKK 370,098 and a net result of DKK -16,645,537 compared with DKK -455,658 the year before. Equity amounted to DKK -4,205,596.

Other financial years